Rxivist logo

The pro-oncogenic adaptor CIN85 inhibits hypoxia-inducible factor prolyl hydroxylase-2

By Nina Kozlova, Daniela Mennerich, Anatoly Samoylenko, Elitsa Y Dimova, Peppi Koivunen, Ekaterina Biterova, Kati Richter, Antti Hassinen, Sakari Kellokumpu, Aki Manninen, Ilkka Miinalainen, Virpi Glumoff, Lloyd Ruddock, Lyudmyla Drobot, Thomas Kietzmann

Posted 09 Nov 2018
bioRxiv DOI: 10.1101/466946 (published DOI: 10.1158/0008-5472.CAN-18-3852)

The family of HIF-prolyl hydroxylases is crucially involved in the regulation of hypoxia-inducible factor (HIF) levels. We have previously shown that the EGFR-adaptor protein CIN85 promotes breast cancer malignancy and HIF-1α stability. These findings suggested that the CIN85-mediated effects occur via interference of proline hydroxylase (PHD)-dependent HIF-α protein degradation and involve a molecular association between CIN85 and PHDs. Indeed, our current study identified CIN85 as a novel binding partner of the main HIF-prolyl hydroxylase PHD2, but not of PHD1 or PHD3. We defined the importance of the N-terminal SH3 domains of CIN85 and the proline-arginine rich region within the amino acids 77-100 in the N-terminus of PHD2 for CIN85-PHD2 complex formation.

Download data

  • Downloaded 325 times
  • Download rankings, all-time:
    • Site-wide: 66,732 out of 118,130
    • In biochemistry: 1,828 out of 3,572
  • Year to date:
    • Site-wide: 65,366 out of 118,130
  • Since beginning of last month:
    • Site-wide: 55,890 out of 118,130

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)